Spero Therapeutics (SPRO) Other Non-Current Liabilities (2016 - 2022)
Spero Therapeutics (SPRO) posted Other Non-Current Liabilities of $100,000 for Q3 2022, unchanged from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Other Non-Current Liabilities (2016 - 2022) Analysis & Trends
At the end of FY2021, Spero Therapeutics' Other Non-Current Liabilities came in at $802,000.
- Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of 10.2% (FY2016 to FY2021).
- In prior years, Spero Therapeutics' Other Non-Current Liabilities was $833,000 in FY2018 (+128.2%) and $365,000 in FY2017 (-26.0%).
- Quarterly Other Non-Current Liabilities has run from a low of $100,000 in Q2 2022 to a high of $1 million in Q1 2022 over five years.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q4 2018, with growth of 128.2%; the weakest was Q2 2019, with a decline of 38.1%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $100,000 (Q2 2022), $1 million (Q1 2022) and $802,000 (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.36 Bn | 1,105.95 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.62 Bn | 536.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.17 Bn | 474.28 Bn | 12.70 Bn |
| 4 | Merck | 368.13 Bn | 322.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.23 Bn | 234.92 Bn | 12.86 Bn |
| 7 | Amgen | 236.68 Bn | 192.08 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.97 Bn | 165.17 Bn | 6.22 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn |
| 10 | Spero Therapeutics | 68.11 Mn | -127.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 802,000.00 |
| Mar 31, 2020 | 200,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Mar 31, 2019 | 223,000.00 |
| Dec 31, 2018 | 833,000.00 |
| Sep 30, 2018 | 290,000.00 |
| Jun 30, 2018 | 323,000.00 |
| Mar 31, 2018 | 327,000.00 |
| Dec 31, 2017 | 365,000.00 |
| Sep 30, 2017 | 399,000.00 |
| Jun 30, 2017 | 200,000.00 |
| Dec 31, 2016 | 493,000.00 |
| Sep 30, 2016 | 2.71 Mn |
API Access
Spero Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();